Daniel Kraft

Who is Daniel Kraft?

Daniel Kraft, M.D. is an NIH funded faculty member affiliated with Stanford. He was on clinical faculty with the UCSF pediatric bone marrow transplantation service and serves as the medicine track chair for Singularity University where he is also executive director for the FutureMed executive program.

Daniel is the founder of StemCor Systems and founder and consulting chief medical officer for RegenMed Systems, a clinical-stage medical device company that develops tools to enable regenerative stem cell therapies. He is the inventor of the MarrowMiner, a minimally invasive device for the harvest of bone marrow derived stem and progenitor cells. This device is being commercialized by Hospira Inc. for use in bone marrow transplantation and by RegenMed Systems for use in regenerative medicine.

Dr. Kraft received a degree in Biochemistry from Brown University and his M.D. from the Stanford University School of Medicine. He completed the Harvard combined residency in Internal Medicine and Pediatrics at the Massachusetts General Hospital and the Boston Children's Hospital, before returning to Stanford for clinical fellowship training in hematology/oncology and bone marrow transplantation and a post-doctoral fellowship with Dr. Irving Weissman. Dr. Kraft is board certified in both Pediatrics and Internal Medicine.